Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

ILMN:US

205.0000 USD 1.8800 0.93%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Illumina Inc (ILMN)

Open: 203.4000 Day's Range: 203.0000 - 205.7300 Volume: 1,088,399
Previous Close: 203.1200 52wk Range: 145.1201 - 213.3300 1-Yr Rtn: +28.77%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 204.9800
  • 1D
  • 1M
  • 1Y
203.1200
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 71.3915
Estimated P/E(12/2015) 59.9941
Relative P/E vs. SPX 3.7998
Earnings Per Share (USD) (ttm) 2.8715
Est. EPS (USD) (12/2015) 3.4170
Est. PEG Ratio 2.5604
Market Cap (M USD) 29,540.50
Shares Outstanding (M) 144.10
30 Day Average Volume 1,351,851
Price/Book (mrq) 18.1975
Price/Sale (ttm) 14.4586
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil